
Portage Biotech Inc. Common Stock
PRTG
PRTG: Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
moreShow PRTG Financials
Recent trades of PRTG by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PRTG's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on PRTG's company Twitter account
Number of mentions of PRTG in WallStreetBets Daily Discussion
Recent insights relating to PRTG
Recent picks made for PRTG stock on CNBC
ETFs with the largest estimated holdings in PRTG
Flights by private jets registered to PRTG